Up Next
Back to Show
Amanpour & Co.
Jennifer Doudna on FDA Approval of First CRISPR Treatments
More than a decade ago, pioneering biochemist Jennifer Doudna co-invented CRISPR, the gene editing technology which earned her the Nobel Prize in chemistry. Now, the very first treatment based on CRISPR has been approved in the U.K. and the U.S., a landmark decision for the treatment of sickle cell disease and for the potential of this rapidly advancing field. Dr. Doudna joins to discuss.
Support Provided By
Season
Unlock with PBS Passport
55:44
Oleksandr Merezhko; Dr. Samer Attar; Isabel Allende; Douglas Belkin
Unlock with PBS Passport
55:47
David J. Bier; Siamak Namazi, Morad Tahbaz and Emad Shargi; Timothy Naftali
Unlock with PBS Passport
55:47
Andrew Coyne; Amos Harel; Clarisse Rosaz Shariyf; Dinaw Mengestu; Daniel Kritenbrink
Unlock with PBS Passport
55:46
Susan Glasser; Dennis Ross; Mary Ziegler; Perri Peltz and Matthew Bergman
Unlock with PBS Passport
55:47
David Pressman; Basel Adra; Yuval Abraham; Rick Steves
Unlock with PBS Passport
55:41
Zvi Solow; Selma van de Perre; Elie Wiesel; Zahra Joya; Jonathan Blitzer
Unlock with PBS Passport
55:46
Stephen Rapp; Angela Patton; Natalie Rae; Eric Schmidt
Unlock with PBS Passport
55:44
Rami Jarrah; Geir Pederson; Jon Finer; Abby Edaburn; Jacob Tice
Unlock with PBS Passport
55:47
Cardinal Blase J. Cupich; Ben Wedeman; Philip Pullella; David Gibson
Unlock with PBS Passport
55:32
Maura Healey; Cyrus Nasseri; Simon Shama
Unlock with PBS Passport
55:47
Kurt Campbell; Marcel Mettelsiefen; Debbie Wei Mullin and Sarah LaFleur
Unlock with PBS Passport
55:40
Michael S. Roth; David Gibson; Kelsey Osgood